< Back to previous page
Researcher
Steven Joniau
- Disciplines:Urology and nephrology
Affiliations
- Urogenital, Abdominal and Plastic Surgery (Division)
Member
From1 Jan 2019 → Today - Woman and Child (Division)
Member
From1 Apr 2013 → 31 Dec 2018
Projects
11 - 19 of 19
- Clinical and preclinical studies of modulators of high-risk prostate cancer with metastatic potentialFrom1 Aug 2016 → 29 Apr 2022Funding: BOF - doctoral mandates, Private funding of national origin - undefined
- Role of hydroxymethylation as an epigenetic mark in prostate cancer biologyFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- Structural optimization of MEL-6 and development towards a prostate cancer therapeuticFrom1 Oct 2015 → 30 Sep 2017Funding: IOF - Industrial Research Fund
- Androgen Actions: from Bench to Clinic (A2B2C).From1 Oct 2014 → 30 Sep 2019Funding: BOF - Concerted Research Project from 1994
- Stem Cell and Stromal Vascular Fraction Treatment for Penile Tunica Albuginea and Urethral FibrosisFrom3 Jul 2014 → 4 Sep 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Androgen receptor functions in androgen insensitivity syndrome and prostate cancerFrom1 Aug 2013 → 2 Jun 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Study of the genetic variations in the TMPRSS2 control regions and their effects on prostate cancer development .From1 Jan 2013 → 31 Dec 2016Funding: FWO research project
- Implementation of functional imaging and molecular diagnostics for patient-tailored treatment of prostate cancer.From15 Sep 2009 → 30 Jun 2015Funding: Ministery of Social Affairs, Public Health and Environment
- Implementation of functional imaging and molecular diagnostics for patient-tailored treatment of prostate cancer.From1 Jan 2009 → 30 Sep 2015Funding: Ministery of Social Affairs, Public Health and Environment
Publications
1 - 10 of 540
- Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters.(2024)
Authors: Alexander Giesen, Steven Joniau
Pages: 231 - 240 - Re: Abiraterone and Olaparib for Metastatic Castration-resistant Prostate Cancer.(2024)
Authors: Alexander Giesen, Frank Claessens, Steven Joniau
Pages: 396 - Salvage vesiculectomy for local prostate cancer recurrence: surgical technique and early post-operative outcomes(2024)
Authors: Alexander Giesen, Kato Rans, Charlien Berghen, Steven Joniau
- PSMA PET/CT and PET/MRI in primary staging of prostate cancer and its effect on patient management(2024)
Authors: Alexander Giesen, Steven Joniau, Koen Van Laere, Michel Koole, Christophe Deroose, Karolien Goffin
Pages: 31 - 54 - Impact of the Standardization of Penile Cancer Care on the Quality of Care, Outcomes, and Academic-driven Centralization in a Single eUROGEN Referral Center.(2024)
Authors: Dirk De Ridder, Anne-Sophie Van Rompuy, Herlinde Dumez, Gert De Meerleer, Karolien Goffin, Hendrik Van Poppel, Steven Joniau, Maarten Albersen
Pages: 57 - 65 - The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects(2023)
Authors: Steven Joniau, Charlien Berghen, Kato Rans, Gert De Meerleer
- Predictors of Recurrence After Metastasis-directed Therapy in Oligorecurrent Prostate Cancer Following Radical Prostatectomy(2023)
Authors: Charlien Berghen, Steven Joniau, Gert De Meerleer
Pages: 582 - 589 - Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool(2023)
Authors: Alexander Giesen, Steven Joniau
Pages: 543 - 552 - Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants(2023)
Authors: Gert De Meerleer, Frank Claessens, Steven Joniau
Pages: 2065 - + - Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer(2023)
Authors: Steven Joniau
Pages: 531 - 535